28 Feb [33] Treatment of Pain in the Older Patient
The assessment of gabapentin (Neurontin) included in this Letter was based on potentially misleading information, as reported by the manufacturer. U.S. litigation in 2009-2010 has revealed that Neurontin’s off-label promotion, which over a relatively short...